Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» NICE
NICE
Clovis' Rubraca, trailing PARP rivals, nabs England coverage thanks to NICE U-turn
Fierce Pharma
Sat, 10/12/19 - 12:32 pm
Clovis Oncology
Rubraca
NICE
UK
PARP inhibitors
Blow to Novartis as NICE rejects migraine drug Aimovig again
Pharmaforum
Thu, 09/26/19 - 10:54 am
Novartis
Aimovig
migraines
NICE
UK cost watchdog recommends Novartis' blindness therapy Luxturna
Yahoo/Reuters
Wed, 09/4/19 - 10:18 am
Novartis
gene therapy
Luxturna
UK
NICE
Spark Therapeutics
GW confident epilepsy drug will get NHS funding despite NICE rejection
Pharmaforum
Fri, 08/23/19 - 12:08 pm
GW Pharma
UK
NHS
NICE
Epidyolex
epilepsy
MSD’s Keytruda plus chemo backed by NICE for lung cancer
Pharmaforum
Fri, 08/9/19 - 10:30 am
Merck
Keytruda
NICE
non-small cell lung cancer
NICE recommends funding for psoriasis and type 1 diabetes drugs
Pharmaforum
Fri, 07/12/19 - 12:14 pm
NICE
UK
NHS
AbbVie
Skyrizi
AstraZeneca
Farxiga
Alnylam's Onpattro back in the game against Ionis, thanks to NICE U-turn
Fierce Pharma
Tue, 07/9/19 - 06:32 pm
Ionis
Tegsedi
RNAi
Alnylam
Onpattro
NICE
After years of delays, NICE backs Celgene’s Revlimid in first-line MM
Pharmaforum
Fri, 05/17/19 - 07:18 pm
Celgene
Revlimid
Multiple Myeloma
NICE
NHS
England
Scotland backs Aimovig for migraine after NICE says no
Pharmaforum
Tue, 04/9/19 - 08:20 am
Scotland
NICE
migraines
Aimovig
Amgen
Novartis
AstraZeneca's Imfinzi gets a lift in lung cancer from England's cost watchdogs
Fierce Pharma
Thu, 03/28/19 - 11:50 am
AstraZeneca
Imfinzi
lung cancer
NICE
UK
NICE provides first scientific advice on patient preference
BioCentury
Sat, 02/16/19 - 04:32 pm
NICE
COPD
Novartis
clinical trials`
NICE backs Takeda’s Alunbrig in second-line lung cancer
Pharmaforum
Sat, 02/16/19 - 12:02 am
NICE
Takeda
Alunbrig
ALK-positive non-small cell lung cancer
Lilly price break reverses NICE’s 'No' ruling on breast cancer drug Verzenio
Fierce Pharma
Fri, 01/18/19 - 12:09 am
Eli Lilly
NICE
Verzenio
breast cancer
NICE turns down Novartis' Aimovig, flagging clinical trial concerns
Biopharma Dive
Fri, 01/11/19 - 08:18 pm
NICE
UK
Amgen
Novartis
migraines
Aimovig
AbbVie’s CLL drug Venclyxto too expensive for NHS, says NICE
Pharmaforum
Fri, 10/26/18 - 09:54 am
NICE
AbbVie
Venclyxto
Roche
Rituxan/MabThera
CLL
NICE spurns Lilly’s breast cancer drug Verzenio in favor of rivals from Pfizer and Novartisspir
Fierce Pharma
Sat, 10/20/18 - 10:37 pm
Lilly
Verzenio
breast cancer
Pfizer
Ibrance
Novartis
Kisqali
NICE
NICE rejects Novartis’ CAR-T in adult lymphoma
Pharmaforum
Wed, 09/19/18 - 11:22 pm
NICE
UK
Novartis
CAR-T
Kymriah
NHS
diffuse large B-cell lymphoma
MS Society protests NICE rejection of Ocrevus for primary progressive MS
BioCentury
Mon, 09/10/18 - 12:16 am
NICE
UK
MS
multiple sclerosis
Ocrevus
ocrelizumab
Roche
UK rejects Gilead's CAR-T cancer cell therapy as too expensive
Reuters
Tue, 08/28/18 - 11:51 am
Yescarta
UK
Europe
CAR-T
NICE
Gilead Sciences
Biogen's Spinraza gets an early no-go from NICE
Biopharma Dive
Wed, 08/15/18 - 09:57 am
Biogen
UK
NICE
Spinraza
SMA
spinal muscular atrophy
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »